Submit Written Testimony for Sarepta's Upcoming FDA Advisory Committee Meeting

PPMD encourages Duchenne community members to submit written testimonies to the FDA Advisory Committee in advance of the upcoming Sarepta Ad Comm meeting. Testimonies must be submitted by January 7th.
Source: Parent Project Muscular Dystrophy - Category: Neurology Source Type: news